|
|
O-GLCNAC HOMEOSTASIS REGULATES MITOCHONDRIAL FUNCTION IN ALZHEIMERS DISEASE |
| 1 R01 AG064227-01A1 |
SLAWSON, CHAD ERIC |
NIA |
2020 |
|
|
Cellular and Molecular Basis of Sleep Loss Neural Injury in Alzheimer Disease |
| 1 R01 AG064231-01A1 |
VEASEY, SIGRID C |
NIA |
2020 |
|
|
Regulation of Microglial Activation State by a Lipid Transporter |
| 1 R01 AG064234-01A1 |
BIEBERICH, ERHARD |
NIA |
2020 |
|
|
Essential roles of DAP12 in tau metabolism and inflammation in Alzheimers disease |
| 1 R01 AG064239-01A1 |
LUO, WENJIE |
NIA |
2020 |
|
|
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome |
| 1 R01 AG064579-01A1 |
FINKBEINER, STEVEN M |
NIA |
2020 |
|
|
Non-contrast MR imaging of blood-brain-barrier permeability in Alzheimers disease |
| 1 R01 AG064792-01A1 |
LU, HANZHANG |
NIA |
2020 |
|
|
Integrative modeling and dynamic prediction of Alzheimers disease |
| 1 R01 AG064803-01 |
LUO, SHENG |
NIA |
2020 |
|
|
Imaging the alpha7 nicotinic acetylcholine receptor in mild cognitive impairment |
| 1 R01 AG065202-01 |
COUGHLIN, JENNIFER MARIE |
NIA |
2020 |
|
|
Innate immune signaling at the synapse in development and pathological Alzheimer’s disease |
| 1 R01 AG065206-01 |
SHATZ, CARLA J |
NIA |
2020 |
|
|
Prospective memory impairment in Parkinson disease-related cognitive decline: Intervention and mechanisms |
| 1 R01 AG065214-01A1 |
FOSTER, ERIN R |
NIA |
2020 |
